Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04354077 · ClinicalTrials.gov registry record · NA

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Recruiting
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT04354077 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 3 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04354077, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

RECRUITING
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the nucleus accumbens (NAc) as adjunctive treatment for treatment-refractory opioid use disorder. This study will include 3 individuals with opioid use disorder and relapsing opioid use despite active participation in a drug addiction treatment program.

Conditions Studied

Interventions

  • DEVICE DBS of the NAc

Study Locations (1)

Pennsylvania

  • AHN Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2022-02-07
Est. Completion 2030-01
Phase NA

What the Registry Record Tells You About NCT04354077

The ClinicalTrials.gov registry entry for NCT04354077 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which DBS of the NAc is the first listed.

NCT04354077 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04354077 about?

NCT04354077 is a clinical study titled "Deep Brain Stimulation Effects In Patients With Opioid Use Disorder". This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the nucleus accumbens (NAc) as adjunctive treatment for treatment-refractory opioid use disorder. This study will include 3 individuals with opioid use disorder and relapsing opioid use despite active partic...

What is the current status of trial NCT04354077?

This trial is currently recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2022-02-07. Estimated completion is 2030-01.

What conditions does trial NCT04354077 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT04354077?

The interventions under investigation include: DBS of the NAc (DEVICE).

Who is sponsoring clinical trial NCT04354077?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04354077 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.